Literature DB >> 25377880

Asthma: the role of low high-density-lipoprotein cholesterol in childhood and adolescence.

Panayiotis K Yiallouros1, Savvas C Savva, Ourania Kolokotroni, Kleanthi Dima, Aikaterini Zerva, Panayiotis Kouis, Jean Bousquet, Nicos Middleton.   

Abstract

BACKGROUND: Several studies have examined the relationship of asthma with serum dyslipidemia and reported positive, negative or no association. Most studies were limited by their cross-sectional design and the wide age range of the participants. In a cohort of children in Cyprus, we explored the association of asthma with serum high-density-lipoprotein cholesterol (HDL-C) at age 16-18 years (follow-up) independently of and in relation to HDL-C at age 11-12 years (baseline).
METHODS: In a case-control design, we recruited active asthmatics (AA; n = 68), current wheezers only (CWO; n = 123) and non-asthmatic controls (n = 660). Logistic regression models were used to evaluate associations of asthma with follow-up serum HDL-C and the role of baseline HDL-C.
RESULTS: At follow-up, mean HDL-C levels in AA and CWO patients were significantly lower than in the controls (47.9 and 49.7 vs. 53.4 mg/dl; p = 0.001 and p = 0.011). We observed significant associations of AA patients with low HDL-C (<15th percentile; OR 2.32, 95% CI 1.16-4.47) that remained significant after further adjustment for baseline HDL-C (OR 2.14, 95% CI 1.06-4.14). Stratification by baseline HDL-C indicated that the association was significant only in those with high baseline HDL-C (OR 2.40, 95% CI 1.03-5.20). Stratification by IgE sensitization showed that the association was pronounced only in subjects who were sensitized (OR 3.41, 95% CI 1.12-9.88).
CONCLUSIONS: Adolescent asthma is associated with low serum HDL-C independent of previous HDL-C levels in childhood. The association appears pronounced in those with a drop in HDL-C levels between childhood and adolescence and in those who have IgE sensitization.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25377880     DOI: 10.1159/000368405

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  4 in total

Review 1.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

2.  Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Cong-Lin Liu; Yi Wang; Mengyang Liao; Marcela M Santos; Cleverson Fernandes; Galina K Sukhova; Jin-Ying Zhang; Xiang Cheng; Chongzhe Yang; Xiaozhu Huang; Bruce Levy; Peter Libby; Gongxiong Wu; Guo-Ping Shi
Journal:  Transl Res       Date:  2016-02-01       Impact factor: 7.012

3.  Shared genetic variants between serum levels of high-density lipoprotein cholesterol and wheezing in a cohort of children from Cyprus.

Authors:  Panayiotis K Yiallouros; Panayiotis Kouis; Ourania Kolokotroni; Sonia Youhanna; Savvas C Savva; Kleanthi Dima; Aikaterini Zerva; Danielle Platt; Nicos Middleton; Pierre Zalloua
Journal:  Ital J Pediatr       Date:  2016-07-13       Impact factor: 2.638

4.  Association of Serum Lipids and Obstructive Lung Disease in Hispanic/Latino Adults of Diverse Backgrounds.

Authors:  Majid Afshar; Donghong Wu; Ramon Durazo-Arvizu; Frank G Aguilar; Ravi Kalhan; Sonia M Davis; Robert Kaplan; Oana L Klein; Eliana P Mende; Maria S Pattany; Martha L Daviglus
Journal:  J Pulm Respir Med       Date:  2017-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.